Results 111 to 120 of about 1,882,441 (191)

Annus Mirabilis - a guide to the 6th European Lupus meeting 3-5 March 2005 [PDF]

, 2005
This article has no ...
Ioannou, Y., Giles, I.P., Bowman, S.J., Rahman, A., Isenburg, D.A.   +4 more
core  

Biological Therapy of Systemic Lupus Erythematosus

, 2022
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder ofunknown etiology. SLE mostly effects women of childbearing age and varies in mild to life- threatening manifestations.
Aharonov, Adi
core  

Irreversible blindness in juvenile systemic lupus erythematosus

, 2011
Blindness caused by severe vasculitis or uveitis is rare in juvenile systemic lupus erythematosus (JSLE) patients. In a 27-year period, 5367 patients were followed at our Paediatric Rheumatology Division and 263 (4.9%) patients had JSLE (American College
AIKAWA, N. E., SILVA, C. A., SALLUM, A. M. E., JESUS, A. A., ALMEIDA, R. T., SA, L. C. F.   +5 more
core   +1 more source

Heterogeneity of macrophage activation syndrome and treatment progression

Frontiers in Immunology
Macrophage activation syndrome (MAS) is a rare complication of autoimmune inflammatory rheumatic diseases (AIIRD) characterized by a progressive and life-threatening condition with features including cytokine storm and hemophagocytosis.
Yuanji Dong, Ting Wang, Huaxiang Wu
doaj   +1 more source

Health Related Quality of Life in Juvenile-Onset Systemic Lupus Erythematosus: A Questionnaire-Based Study. [PDF]

Matern Child Health J, 2023
Eid R, Hammad A, Korkor MS, Fathy AA, Abd El-Ghafaar DM, Rakha S, Hamdy N.   +6 more
europepmc   +1 more source

Kikuchi-Fujimoto disease and systemic lupus erythematosus

, 2016
Diego F Baenas,1 Fernando A Diehl,1 María J Haye Salinas,2 Verónica Riva,3 Ana Diller,3 Pablo A Lemos1,4 1Clinical Medicine Department, 2Rheumatology Department, 3Pathology Department, Hospital Privado Universitario de Córdoba ...
Baenas DF, Riva V, Diehl FA, Haye Salinas MJ, Lemos PA, Diller A   +5 more
core  

IL12B and IL17 genes polymorphisms associated with differential susceptibility to juvenile idiopathic arthritis and juvenile-onset systemic lupus erythematosus in Chinese children. [PDF]

Medicine (Baltimore), 2023
Zhang M, Peng L, Li W, Duan Y, Liu X, Chen S, Deng J, Liu X.   +7 more
europepmc   +1 more source

Risk factors for subsequent lupus nephritis in patients with juvenile-onset systemic lupus erythematosus: a retrospective cohort study. [PDF]

Pediatr Rheumatol Online J, 2023
Hsu TC, Yang YH, Wang LC, Lee JH, Yu HH, Lin YT, Hu YC, Chiang BL.   +7 more
europepmc   +1 more source

Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis

Frontiers in Immunology
Lupus nephritis (LN), present in 30%–50% of systemic lupus erythematosus (SLE) patients, often necessitates standard immunosuppressive therapy (glucocorticoids, MMF, CYC) as suggested by the European League Against Rheumatism/European Renal Association ...
Decimo Silvio Chiarenza, Raul Mancini, Carolina Bigatti, Carolina Bigatti, Gianluca Caridi, Alessandro Consolaro, Alessandro Consolaro, Valentina Natoli, Valentina Natoli, Gabriele Mortari, Xhuliana Kajana, Francesca Lugani, Marco Gattorno, Marco Gattorno, Gian Marco Ghiggeri, Edoardo La Porta, Gabriele Gaggero, Enrico E. Verrina, Andrea Angeletti   +18 more
doaj   +1 more source

Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus

, 2013
The aim of this study was to evaluate the presence of subclinical cardiovascular disease (CVD) and its relation to risk factors, particularly hypertension in juvenile-onset systemic lupus erythematosus (SLE)
Arisoy, Nil, Kasapcopur, Ozgur, Gokalp, Selman, Tasdemir, Mehmet, Canpolat, Nur, Sever, Lale, Bor, Meltem, Caliskan, Salim   +7 more
core   +1 more source